Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Strawn

Showing results (31-40 of 233) with videos related to

Pageof 24
Sort By:
Depression and Anxiety|December 7, 2017
Individuation for a DSM-5 disorder: Adult separation anxietyJeffrey R Strawn, Eric T Dobson
The Journal of Clinical Psychiatry|May 4, 2006
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndromeJeffrey R Strawn, Paul E Keck
Child and Adolescent Psychiatric Clinics of North America|May 18, 2023
Advances in Pharmacotherapy for Pediatric Anxiety DisordersCassandra M Nicotra, Jeffrey R Strawn
Journal of Affective Disorders|November 12, 2025
Trajectories and predictors of depressive and anxiety symptom improvement with adjunctive cariprazine in antidepressant-treated adults with major depression: A Bayesian mega-analysis of two randomized trialsJeffrey R Strawn, Jeffrey A Mills
Journal of Child and Adolescent Psychopharmacology|May 29, 2020
A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-UpRobert L Findling, Emily McCusker, Jeffrey R Strawn
Clinical and Translational Science|December 16, 2021
Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatryStephani L Stancil, John Tumberger, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|February 20, 2024
Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond <i>HLA-B</i>*15:02Stephani L Stancil, Tracy Sandritter, Jeffrey R Strawn
Focus (American Psychiatric Publishing)|May 8, 2023
Pediatric Psychopharmacology for Depressive and Anxiety DisordersJeffrey R Strawn, Samuel Vaughn, Laura B Ramsey
Psychiatric Services (Washington, D.C.)|February 1, 2023
Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder: In ReplyJeffrey A Mills, Vikram Suresh, Jeffrey R Strawn
Journal of Psychiatric Practice|January 21, 2025
Licensure Actions Against Psychiatric Clinicians: A Cohort Analysis of National Practitioner Database ReportsAkanksha Dadlani, Jeffrey A Mills, Jeffrey R Strawn, et al.
Pageof 24

Showing results (31-40 of 233) with videos related to

Sort By:
Pageof 24
Depression and Anxiety|December 7, 2017
Individuation for a DSM-5 disorder: Adult separation anxietyJeffrey R Strawn, Eric T Dobson
The Journal of Clinical Psychiatry|May 4, 2006
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndromeJeffrey R Strawn, Paul E Keck
Child and Adolescent Psychiatric Clinics of North America|May 18, 2023
Advances in Pharmacotherapy for Pediatric Anxiety DisordersCassandra M Nicotra, Jeffrey R Strawn
Journal of Affective Disorders|November 12, 2025
Trajectories and predictors of depressive and anxiety symptom improvement with adjunctive cariprazine in antidepressant-treated adults with major depression: A Bayesian mega-analysis of two randomized trialsJeffrey R Strawn, Jeffrey A Mills
Journal of Child and Adolescent Psychopharmacology|May 29, 2020
A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-UpRobert L Findling, Emily McCusker, Jeffrey R Strawn
Clinical and Translational Science|December 16, 2021
Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatryStephani L Stancil, John Tumberger, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|February 20, 2024
Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond <i>HLA-B</i>*15:02Stephani L Stancil, Tracy Sandritter, Jeffrey R Strawn
Focus (American Psychiatric Publishing)|May 8, 2023
Pediatric Psychopharmacology for Depressive and Anxiety DisordersJeffrey R Strawn, Samuel Vaughn, Laura B Ramsey
Psychiatric Services (Washington, D.C.)|February 1, 2023
Socioeconomic Predictors of Treatment Outcomes Among Adults With Major Depressive Disorder: In ReplyJeffrey A Mills, Vikram Suresh, Jeffrey R Strawn
Journal of Psychiatric Practice|January 21, 2025
Licensure Actions Against Psychiatric Clinicians: A Cohort Analysis of National Practitioner Database ReportsAkanksha Dadlani, Jeffrey A Mills, Jeffrey R Strawn, et al.
Pageof 24